Deutsch English Français

Contact

EP2126081

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2126081

EP2126081 - NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 10.01.2014 Database last updated on 19.10.2024
Most recent event Tooltip	10.01.2014	Application deemed to be withdrawn	published on 12.02.2014 [2014/07]
Applicant(s)	For all designated states Marina Biotech, Inc. 3830 Monte Villa Parkway Bothell WA 98021-7266 / US
	[2010/43]
Former [2009/49]	For all designated states MDRNA, Inc. 3830 Monte Villa Parkway Bothell, WA 98021-7266 / US
Inventor(s)	01 / QUAY, Steven, C. Pmb 421, 14241 N.e. Woodinville-duvall Road Woodinville, WA 98072 / US
	02 / MCSWIGGEN, James 3669 Roundtree Court Boulder, Colorado 80304 / US
	03 / VAISH, Narendra, K. 13014 Ne 137th Place Kirkland, WA 98034 / US
	04 / AHMADIAN, Mohammad 3230 Rancho Quartillo Carlsbad, California 92009 / US
	[2010/03]
Former [2009/49]	01 / QUAY, Steven, C. Pmb 421, 14241 N.e. Woodinville-duvall Road Woodinville, WA 98072 / US
	02 / MCSWIGGEN, James 12605 Ne 183rd Street, 1022 Bothell, WA 98011 / US
	03 / VAISH, Narendra, K. 13014 Ne 137th Place Kirkland, WA 98034 / US
	04 / AHMADIAN, Mohammad 3106 200th Place S.e. Bothell, WA 98012 / US
Representative(s)	MacLean, Martin Robert, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
	[N/P]
Former [2009/49]	MacLean, Martin Robert, et al Mathys & Squire LLP 120 Holborn London EC1N 2SQ / GB
Application number, filing date	08731039.7	28.02.2008
	[2009/49]
	WO2008US55385
Priority number, date	US20070934940P	02.03.2007 Original published format: US 934940 P
	US20070934930P	16.03.2007 Original published format: US 934930 P
	US20070956093P	15.08.2007 Original published format: US 956093 P
	[2009/49]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2008109381
	Date:	12.09.2008
	Language:	EN
	[2008/37]
	Type:	A2 Application without search report
	No.:	EP2126081
	Date:	02.12.2009
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.09.2008 takes the place of the publication of the European patent application.
	[2009/49]
Search report(s)	International search report - published on:	EP	30.10.2008
Classification	IPC:	C12N15/11, A61K31/713	[2009/49]
	CPC:	C12N15/113 (EP,US); A61P15/08 (EP); A61P29/00 (EP); A61P43/00 (EP); A61P9/10 (EP); A61P9/12 (EP); (+) C12N2310/14 (EP,US); C12N2310/3231 (EP,US); C12N2310/53 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2009/49]
Title	German:	NUKLEINSÄUREVERBINDUNGEN ZUR HEMMUNG DER HIF1A-GENEXPRESSION UND IHRE VERWENDUNG	[2009/49]
	English:	NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF	[2009/49]
	French:	COMPOSÉS D'ACIDE NUCLÉIQUE POUR INHIBER L'EXPRESSION DE GÈNE HIF1A ET UTILISATIONS DE CEUX-CI	[2009/49]
Entry into regional phase	14.09.2009	National basic fee paid
	14.09.2009	Designation fee(s) paid
	14.09.2009	Examination fee paid
Examination procedure	14.09.2009	Amendment by applicant (claims and/or description)
	14.09.2009	Examination requested [2009/49]
	11.10.2010	Despatch of a communication from the examining division (Time limit: M06)
	21.04.2011	Reply to a communication from the examining division
	03.09.2013	Application deemed to be withdrawn, date of legal effect [2014/07]
	27.09.2013	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/07]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.10.2010
Fees paid	Renewal fee
	14.01.2010	Renewal fee patent year 03
	20.01.2011	Renewal fee patent year 04
	29.02.2012	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	28.02.2013	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]WO2004042024 (UNIV PENNSYLVANIA [US], et al) [Y] 1-24 * page 1, paragraphs 2-5 * * page 16, paragraph 4 - page 17, paragraph 1 *;
		[Y]WO03070918 (RIBOZYME PHARM INC [US], et al) [Y] 1-24 * page 15, line 23 - page 30, line 2 *;
		[PY]WO2007107162 (UNIV SYDDANSK [DK], et al) [PY] 1-24 * figures 1-6 *;
		[PY]WO2007056153 (NASTECH PHARM CO [US], et al) [PY] 1-24 * page 4, lines 14-26 *
		[YD] - LEUSCHNER P J F ET AL, "Cleavage of the siRNA passenger strand during RISC assembly in human cells", EMBO REPORTS, XX, XX, (20060301), vol. 7, no. 3, pages 314 - 320, XP002467845 [YD] 1-24 * page 3178, column L, paragraph 1 - column R, paragraph 1 *
		[A] - MATRANGA CHRISTIAN ET AL, "Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes", CELL,, (20051101), vol. 123, no. 4, pages 607 - 620, XP002484663 [A] 1-24 * figures 3,4 * DOI: http://dx.doi.org/10.1016/j.cell.2005.08.044
		[A] - MILLS JANINE B ET AL, "Origin of the intrinsic rigidity of DNA", NUCLEIC ACIDS RESEARCH,, (20040101), vol. 32, no. 13, pages 4055 - 4059, XP002484664 [A] 1-24 * figure 1 * DOI: http://dx.doi.org/10.1093/nar/gkh740
		[PY] - BRAMSEN J B ET AL, "Improved silencing properties using small internally segmented interfering RNAs", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, (20070728), vol. 35, no. 17, ISSN 0305-1048, pages 5886 - 5897, XP002467844 [PY] 1-24 * page 5893, column R, paragraph 2 - page 5895, column L, paragraph 2 * DOI: http://dx.doi.org/10.1093/nar/gkm548

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p